Abstract
An 18-month report on the safety and efficacy of rapid intravenous velaglucerase alfa infusions in naïve patients with Gaucher disease
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.ymgme.2021.11.038
Copy DOIJournal: Molecular Genetics and Metabolism | Publication Date: Feb 1, 2022 |
An 18-month report on the safety and efficacy of rapid intravenous velaglucerase alfa infusions in naïve patients with Gaucher disease
Join us for a 30 min session where you can share your feedback and ask us any queries you have